Cargando…
Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system
BACKGROUND: There is concern that increasingly common use of patient assistance programs (PAPs), out-of-pocket assistance provided by manufacturers or foundations, distorts our understanding of patient behavior and insurance design incentives. Yet the current literature on prescription drug cost sha...
Autores principales: | Brouwer, Elizabeth, Yeung, Kai, Barthold, Douglas, Hansen, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391270/ https://www.ncbi.nlm.nih.gov/pubmed/34057391 http://dx.doi.org/10.18553/jmcp.2021.27.6.732 |
Ejemplares similares
-
The Promise of Specialty Pharmaceuticals: Are They Worth the Price?
por: Sullivan, Sean D.
Publicado: (2008) -
Variation in Prices Charged to Patients for Specialty Intraocular Lenses Inserted during Universally Covered Cataract Surgery
por: Robert, Joshua M., et al.
Publicado: (2012) -
Repricing Specialty Hospital Outpatient Services Using Ambulatory Surgery Center Prices
por: Healy, Deborah, et al.
Publicado: (2007) -
Clinical and economic impact of a specialty care management program
among patients with multiple sclerosis: a cohort study
por: Tan, H, et al.
Publicado: (2010) -
Specialty Grand Challenge—Assisted Reproduction
por: Lunenfeld, Eitan
Publicado: (2021)